Ronald Lloyd - Baxalta President

President

Mr. Ronald K. Lloyd was appointed as Executive Vice President President Immunology of the Company on completion of separation
Age 53
Phone224-940-2000
Webhttp://www.baxalta.com
Lloyd has more than 25 years of industry experience. He has served as Baxter’s Global Franchise Head for BioTherapeutics since 2014 and is expected to continue in that role until the separation is completed. From 2011 to 2013, Mr. Lloyd served as General Manager, BioScience US Region. Previous roles at Baxter include General Manager, Regenerative Medicine and Vice President of Global Marketing. Prior to joining Baxter in 2003, Mr. Lloyd held key positions in marketing and business development at Abbott La boratories and Anaquest, a division of British Oxygen Corporationrationrationration.

Baxalta Management Efficiency

The company has return on total asset (ROA) of 0.11 % which means that it generated a profit of $0.11 on every $100 spent on assets. This is way below average. Baxalta's management efficiency ratios could be used to measure how well Baxalta manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 5.27 B in total debt with debt to equity ratio (D/E) of 1.33, which is about average as compared to similar companies. Baxalta has a current ratio of 2.42, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Baxalta until it has trouble settling it off, either with new capital or with free cash flow. So, Baxalta's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baxalta sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baxalta to invest in growth at high rates of return. When we think about Baxalta's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Mike RoetzelTyson Foods
55
Deck SloneAlbertsons Companies
51
Sharon McCollamAlbertsons Companies
61
Mary OleksiukTyson Foods
56
Stephen StoufferTyson Foods
59
Scott RouseTyson Foods
56
Robert DimondAlbertsons Companies
58
Gary KniselyHanover Foods
75
Yoshihide HataNH Foods
65
John LorsonAlbertsons Companies
53
Scott SpradleyTyson Foods
55
Peitro GiraffaHanover Foods
62
Christopher LangholzTyson Foods
57
Andrew CallahanTyson Foods
49
Paul LangAlbertsons Companies
54
Takeo KudoNH Foods
N/A
Doug RamseyTyson Foods
50
Johanna SoderstromTyson Foods
53
Justin WhitmoreTyson Foods
37
Howell CarperTyson Foods
61
Sally GrimesTyson Foods
46
Baxalta Incorporated, a biopharmaceutical company, develops, manufactures, and markets a portfolio of solutions primarily for the treatment of hemophilia, immunology, and oncology worldwide. Baxalta (BXLT) is traded on New York Stock Exchange in USA and employs 17,000 people.

Management Performance

Baxalta Leadership Team

Elected by the shareholders, the Baxalta's board of directors comprises two types of representatives: Baxalta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baxalta. The board's role is to monitor Baxalta's management team and ensure that shareholders' interests are well served. Baxalta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baxalta's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Gavin, Independent Director
John Glasspool, Executive Vice President Head - Corporate Strategy and Customer Operations
Patrice Zagame, Executive Vice President and Presidentident - Intercontinental
Robert Hombach, CFO, Chief Operations Officer and Executive VP
Blake Devitt, Independent Director
AnneMarie Law, Executive Vice President Head of Human Resources
John Orloff, Executive Vice President Head of Research & Development, Chief Scientific Officer
Ludwig Hantson, CEO and President and Director
Peter Edwards, Executive Vice President General Counsel
Gail Fosler, Independent Director
Francois Nader, Independent Director
Karen Ferrante, Independent Director
John Forsyth, Independent Director
Wayne Hockmeyer, Independent Non-Executive Chairman of the Board
Dagmar RosaBjorkeson, Executive Vice President and Presidentident - Biosimilars
John McCoy, Senior Vice President Controller
Brian Goff, Executive VP and President of Hematology
Ronald Lloyd, Executive Vice President and Presidentident - Immunology
Jacopo Leonardi, Executive Vice President and President Immunology
Albert Stroucken, Independent Director
David Meek, Executive Vice President and Presidentident - Oncology

Baxalta Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Baxalta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Baxalta in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Baxalta's short interest history, or implied volatility extrapolated from Baxalta options trading.

Pair Trading with Baxalta

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baxalta position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baxalta will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to FedEx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FedEx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FedEx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FedEx to buy it.
The correlation of FedEx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FedEx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FedEx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FedEx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Baxalta Stock

If you are still planning to invest in Baxalta check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baxalta's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal